KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Tax Provisions: 2010-2025

Historic Tax Provisions for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $19.8 million.

  • Opko Health's Tax Provisions fell 15.85% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 31.59%. This contributed to the annual value of $42.8 million for FY2024, which is 865.61% up from last year.
  • Opko Health's Tax Provisions amounted to $19.8 million in Q3 2025, which was up 240.61% from -$14.1 million recorded in Q2 2025.
  • Opko Health's Tax Provisions' 5-year high stood at $23.5 million during Q3 2024, with a 5-year trough of -$40.3 million in Q3 2022.
  • Over the past 3 years, Opko Health's median Tax Provisions value was $1.2 million (recorded in 2023), while the average stood at $4.3 million.
  • In the last 5 years, Opko Health's Tax Provisions skyrocketed by 448.00% in 2024 and then tumbled by 4,928.21% in 2025.
  • Over the past 5 years, Opko Health's Tax Provisions (Quarterly) stood at $7.5 million in 2021, then crashed by 326.45% to -$17.0 million in 2022, then skyrocketed by 64.54% to -$6.0 million in 2023, then spiked by 448.00% to $20.9 million in 2024, then fell by 15.85% to $19.8 million in 2025.
  • Its Tax Provisions stands at $19.8 million for Q3 2025, versus -$14.1 million for Q2 2025 and -$5.8 million for Q1 2025.